한글목차

세계 시티콜린 성분 시장 규모는 조사 기간 동안 연평균 9.59%의 높은 성장률을 기록할 것으로 예상됩니다.

이 보고서는 세계 시티콜린 성분 시장을 조사 분석하여 시장 역학, 지역 및 부문 분석, 기업 개요 등을 제공합니다.

목차

제1장 주요 요약

• 세계의 시티콜린 성분 시장 : 형상별
• 세계의 시티콜린 성분 시장 : 용도별
• 세계의 시티콜린 성분 시장 : 유통 채널별
• 세계의 시티콜린 성분 시장 : 지역별

제2장 시장 서론

제3장 조사 방법

제4장 시장 역학

• 서론
• 성장 촉진요인
  • 뉴트라슈티컬, 식이보충제 산업으로부터의 수요 증가
  • 진행중인 연구개발
  • 성장 촉진요인의 영향 분석
• 성장 억제요인
  • 식이보충제에서 시티콜린 성분의 한정적인 임상 증거
  • 시티콜린 성분의 가격 변동성
  • 성장 억제요인의 영향 분석
• 기회
  • 제제 혁신
• 세계 경제에 대한 COVID-19의 영향
• 세계의 시티콜린 성분 시장에 대한 COVID-19의 영향
• 공급망에 대한 영향
  • 생산 억제요인
  • 소비자 구매 행동에 대한 영향
  • 소매 매출에 대한 영향(온라인, 직접)

제5장 시장 요인 분석

• 공급망/밸류체인 분석
  • 원재료 공급업체
  • 제조
  • 공급업체/판매업체
  • 최종사용자
• Porter's Five Forces 분석 모델

제6장 세계의 시티콜린 성분 시장 : 형상별

• 개요
• 세계의 시티콜린 성분 시장 규모, 시장 추정과 예측 : 형상별(2019-2030년)

제7장 세계의 시티콜린 성분 시장 : 용도별

• 개요
• 세계의 시티콜린 성분 시장 규모, 시장 추정과 예측 : 용도별(2019-2030년)

제8장 세계의 시티콜린 성분 시장 : 유통 채널별

• 개요
• 세계의 시티콜린 성분 시장 규모, 시장 추정과 예측 : 유통 채널별(2019-2030년)

제9장 세계의 시티콜린 성분 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 러시아
  • 베네룩스
  • 북유럽 국가
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주·뉴질랜드
  • 한국
  • 기타 아시아태평양
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 중동 및 아프리카
  • GCC 국가
  • 터키
  • 북아프리카
  • 남아프리카공화국

제10장 경쟁 상황

• 경쟁 개요
• 경쟁 벤치마킹
• 세계 시티콜린 성분 시장의 주요 기업

제11장 기업 개요

• KYOWA HAKKO BIO CO., LTD.
• PRESCRIBED FOR LIFE
• LIFE LAB SUPPLEMENTS
• NOW FOODS
• MINDBODYGREEN LLC
• CREATE YOUR OWN SUPPLEMENT(CYOS)
• PERFORMANCE LAB GROUP LTD
• PURE ENCAPSULATIONS, LLC

제12장 부록

영문목차

Market Overview

Citicoline as an ingredient Market is expected to register a significant CAGR of 9.59% during the review period. Citicoline, a vital part in mental wellbeing supplements, saw a flood in prominence because of developing mindfulness about cerebrum wellbeing and mental upgrade. This uplifted interest was driven by a maturing populace looking for answers for memory and mental deterioration, as well as a rising interest in nootropic items among more youthful purchasers. Moreover, research concentrates on supporting citicoline's possible advantages for neurological circumstances like Alzheimer's sickness and stroke added to its market energy.

One of the vital parts of this driver is the continuous logical research into Citicoline as an ingredient's instruments of activity and its impacts on mental wellbeing and neurological problems. Researchers are directing investigations to more readily comprehend how Citicoline as an ingredient communicates with the mind and its capability to further develop memory, improve center, and safeguard against mental degradation. These examinations give important experiences into the ingredient's adequacy and wellbeing, which thus impart trust in item makers and customers the same. Notwithstanding its part in logical research, the Research and development driver reaches out to the advancement of novel conveyance frameworks and details that improve Citicoline as an ingredient's bioavailability. This is critical for streamlining its viability in different items, going from conventional cases and tablets to further developed definitions like liposomal or sublingual conveyance strategies. These advancements permit Citicoline as an ingredient to be more effectively consumed by the body, possibly expanding its helpful effect.

Market Segmentation

Based on Form, the Citicoline as an ingredient Market segmentation includes powder and liquid. Citicoline powder is a popular form of this nootropic compound.

Based on Application, the Market has been segmented into dietary supplements and others.

Based on distribution channels, the Citicoline as an ingredient Market has been classified as direct and indirect.

Regional Insights

Europe Citicoline as an ingredient market has held the biggest market divide between all the region in the Citicoline as an ingredient Market. North America represents the biggest market share in 2022. The citicoline as an ingredient market in the US is vigorous and dynamic. With a solid spotlight on wellbeing and health, the interest for dietary enhancements and useful food varieties containing citicoline has consistently expanded. The US flaunts a deeply grounded dietary enhancement industry, with customers effectively looking for items that advance mental wellbeing and by and large prosperity.

In Canada, the citicoline as an ingredient market is encountering development, even though it isn't quite so adult as the US market. The Canadian populace's rising consciousness of wellbeing and health has prompted a rising interest in dietary enhancements and utilitarian food sources containing citicoline. The administrative climate in Canada guarantees that items containing citicoline fulfill wellbeing and quality guidelines, which adds to purchaser trust.

The Citicoline as an Ingredient market in Europe is encountering striking development, mirroring a mainland wide interest in mental wellbeing and mind capability upgrade. Citicoline, otherwise called CDP-Choline, is a compound perceived for its likely mental and neuroprotective advantages. It is a sought-after ingredient in different item classes, including dietary enhancements, and utilitarian food varieties.

Major Players

Key Companies in the Citicoline as an ingredient market include Kyowa Hakko Bio Co., Ltd., Prescribed For Life, Life Lab Supplements, NOW Foods, Mindbodygreen LLC, Create Your Own Supplement, Performance Lab Group Ltd., and Pure Encapsulations.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

• 1.1.1 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY FORM 16
• 1.1.2 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY APPLICATION 17
• 1.1.3 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY DISTRIBUTION CHANNEL 18
• 1.1.4 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY REGION 19

2 MARKET INTRODUCTION 20

• 2.1 DEFINITION 20
• 2.2 SCOPE OF THE STUDY 20
• 2.3 MARKET STRUCTURE 20
• 2.4 KEY BUYING CRITERIA 21

3 RESEARCH METHODOLOGY 22

• 3.1 RESEARCH PROCESS 22
• 3.2 PRIMARY RESEARCH 23
• 3.3 SECONDARY RESEARCH 24
• 3.4 MARKET SIZE ESTIMATION 24
• 3.5 TOP DOWN & BOTTOM-UP APPROACH 25
• 3.6 FORECAST MODEL 26
• 3.7 LIST OF ASSUMPTIONS 27

4 MARKET DYNAMICS 28

• 4.1 INTRODUCTION 28
• 4.2 DRIVERS 29
  • 4.2.1 RISING DEMAND FROM NUTRACEUTICAL AND DIETARY SUPPLEMENT INDUSTRY 29
  • 4.2.2 ONGOING RESEARCH AND DEVELOPMENT 29
  • 4.2.3 DRIVERS IMPACT ANALYSIS 30
• 4.3 RESTRAINTS 30
  • 4.3.1 LIMITED CLINICAL EVIDENCE FOR CITICOLINE AS AN INGREDIENT IN DIETARY SUPPLEMENTS 30
  • 4.3.2 PRICE VOLATILITY IN THE CITICOLINE INGREDIENT 31
  • 4.3.3 RESTRAINTS IMPACT ANALYSIS 31
• 4.4 OPPORTUNITIES 32
  • 4.4.1 INNOVATION IN FORMULATIONS 32
• 4.5 IMPACT OF COVID-19 ON GLOBAL ECONOMY 33
• 4.6 IMPACT OF COVID-19 ON THE GLOBAL CITICOLINE AS AN INGREDIENT MARKET 33
• 4.7 SUPPLY CHAIN IMPACT 33
  • 4.7.1 PRODUCTION CONSTRAINTS 34
  • 4.7.2 IMPACT ON CONSUMER BUYING BEHAVIOR 34
  • 4.7.3 IMPACT ON RETAIL SALES (ONLINE AND DIRECT) 34

5 MARKET FACTOR ANALYSIS 35

• 5.1 SUPPLY/VALUE CHAIN ANALYSIS 35
  • 5.1.1 RAW MATERIALS SUPPLIERS 35
  • 5.1.2 MANUFACTURING 36
  • 5.1.3 SUPPLIERS/DISTRIBUTORS 36
  • 5.1.4 END-USERS 36
• 5.2 PORTER'S FIVE FORCES MODEL 37
  • 5.2.1 THREAT OF NEW ENTRANTS 38
  • 5.2.2 BARGAINING POWER OF SUPPLIERS 38
  • 5.2.3 BARGAINING POWER OF BUYERS 38
  • 5.2.4 THREAT OF SUBSTITUTES 38
  • 5.2.5 INTENSITY OF RIVALRY 38

6 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY FORM 39

• 6.1 OVERVIEW 39
• 6.2 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE, MARKET ESTIMATES & FORECAST BY FORM, 2019-2030 40
  • 6.2.1 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE: MARKET ESTIMATES & FORECAST BY FORM, 2019-2030 40

7 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY APPLICATION 41

• 7.1 OVERVIEW 41
• 7.2 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE, MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 42
  • 7.2.1 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE: MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 42

8 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY DISTRIBUTION CHANNEL 43

• 8.1 OVERVIEW 43
• 8.2 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE, MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44
  • 8.2.1 GLOBAL CITICOLINE AS AN INGREDIENT MARKET SIZE: MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44

9 GLOBAL CITICOLINE AS AN INGREDIENT MARKET, BY REGION 45

• 9.1 OVERVIEW 45
• 9.2 NORTH AMERICA 47
  • 9.2.1 U.S. 49
  • 9.2.2 CANADA 50
  • 9.2.3 MEXICO 51
• 9.3 EUROPE 53
  • 9.3.1 GERMANY 55
  • 9.3.2 UK 56
  • 9.3.3 FRANCE 57
  • 9.3.4 ITALY 58
  • 9.3.5 SPAIN 59
  • 9.3.6 RUSSIA 60
  • 9.3.7 BENELUX 61
  • 9.3.8 NORDICS 62
  • 9.3.9 REST OF EUROPE 63
• 9.4 ASIA PACIFIC 65
  • 9.4.1 CHINA 68
  • 9.4.2 INDIA 69
  • 9.4.3 JAPAN 70
  • 9.4.4 AUSTRALIA & NEW ZEALAND 71
  • 9.4.5 SOUTH KOREA 72
  • 9.4.6 REST OF ASIA PACIFIC 73
• 9.5 SOUTH AMERICA 74
  • 9.5.1 BRAZIL 76
  • 9.5.2 ARGENTINA 77
  • 9.5.3 REST OF SOUTH AMERICA 78
• 9.6 MIDDLE EAST & AFRICA 80
  • 9.6.1 GCC COUNTRIES 82
  • 9.6.2 TURKEY 83
  • 9.6.3 NORTHERN AFRICA 84
  • 9.6.4 SOUTHERN AFRICA 85

10 COMPETITIVE LANDSCAPE 86

• 10.1 COMPETITIVE OVERVIEW 86
• 10.2 COMPETITIVE BENCHMARKING 86
• 10.3 MAJOR PLAYERS IN THE GLOBAL CITICOLINE AS AN INGREDIENT MARKET 87

11 COMPANY PROFILES 88

• 11.1 KYOWA HAKKO BIO CO., LTD. 88
  • 11.1.1 COMPANY OVERVIEW 88
  • 11.1.2 FINANCIAL OVERVIEW 88
  • 11.1.3 PRODUCTS OFFERED 88
  • 11.1.4 KEY DEVELOPMENTS 88
  • 11.1.5 SWOT ANALYSIS 89
  • 11.1.6 KEY STRATEGIES 89
• 11.2 PRESCRIBED FOR LIFE 90
  • 11.2.1 COMPANY OVERVIEW 90
  • 11.2.2 FINANCIAL OVERVIEW 90
  • 11.2.3 PRODUCTS OFFERED 90
  • 11.2.4 KEY DEVELOPMENTS 90
  • 11.2.5 SWOT ANALYSIS 91
  • 11.2.6 KEY STRATEGIES 91
• 11.3 LIFE LAB SUPPLEMENTS 92
  • 11.3.1 COMPANY OVERVIEW 92
  • 11.3.2 FINANCIAL OVERVIEW 92
  • 11.3.3 PRODUCTS/SERVICES OFFERED 92
  • 11.3.4 KEY DEVELOPMENTS 92
  • 11.3.5 SWOT ANALYSIS 93
  • 11.3.6 KEY STRATEGIES 93
• 11.4 NOW FOODS 94
  • 11.4.1 COMPANY OVERVIEW 94
  • 11.4.2 FINANCIAL OVERVIEW 94
  • 11.4.3 PRODUCTS/SERVICES OFFERED 94
  • 11.4.4 KEY DEVELOPMENTS 94
  • 11.4.5 SWOT ANALYSIS 95
  • 11.4.6 KEY STRATEGIES 95
• 11.5 MINDBODYGREEN LLC 96
  • 11.5.1 COMPANY OVERVIEW 96
  • 11.5.2 FINANCIAL OVERVIEW 96
  • 11.5.3 PRODUCTS/SERVICES OFFERED 96
  • 11.5.4 KEY DEVELOPMENTS 96
  • 11.5.5 SWOT ANALYSIS 97
  • 11.5.6 KEY STRATEGIES 97
• 11.6 CREATE YOUR OWN SUPPLEMENT (CYOS) 98
  • 11.6.1 COMPANY OVERVIEW 98
  • 11.6.2 FINANCIAL OVERVIEW 98
  • 11.6.3 PRODUCTS/SERVICES OFFERED 98
  • 11.6.4 KEY DEVELOPMENTS 98
  • 11.6.5 SWOT ANALYSIS 99
  • 11.6.6 KEY STRATEGIES 99
• 11.7 PERFORMANCE LAB GROUP LTD 100
  • 11.7.1 COMPANY OVERVIEW 100
  • 11.7.2 FINANCIAL OVERVIEW 100
  • 11.7.3 PRODUCTS/SERVICES OFFERED 100
  • 11.7.4 KEY DEVELOPMENTS 100
  • 11.7.5 SWOT ANALYSIS 101
  • 11.7.6 KEY STRATEGIES 101
• 11.8 PURE ENCAPSULATIONS, LLC 102
  • 11.8.1 COMPANY OVERVIEW 102
  • 11.8.2 FINANCIAL OVERVIEW 102
  • 11.8.3 PRODUCTS/SERVICES OFFERED 102
  • 11.8.4 KEY DEVELOPMENTS 102
  • 11.8.5 SWOT ANALYSIS 103
  • 11.8.6 KEY STRATEGIES 103

12 APPENDIX 104

• 12.1 REFERENCES 104